Diabetic macular edema and macular edema with retinal vein occlusion.
Conditions
Interventions
Aflibercept(40mg) simple injection
Treatment-lessness (nomal)
Sponsors
Tokyo Women's Medical University Yachiyo Medical center
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Patients whi are outpatients or hospitalized for ophthalmology at Tokyo Women's Medical College Yachiyo Medical Center. Patients diagnosed with macular edema associated with diabetic retinopathy or retinal vein occulusion. Patients who undergo the intravitreal injection of anti-VEGF drugs or catacact surgery.
Exclusion criteria
Exclusion criteria: Patients receiving the intravitreal injection of anti-VEGF drugs with in 3 months of sampling. Patients receiving the injection suspended steroid within 6 months of sampling. Patients without light perception. Patients who undergo the intraocular surgery within 3 months of sampling. In addition, patients who the research director judged as inappropriate as suject.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Relationship between macular edema associated with diabetic retinopathy or retinal vein occlusion and type of cytokines(cytokine levels in the aqueous humor, tear fluid and blood). | — |
Secondary
| Measure | Time frame |
|---|---|
| Relationship between cytokine levels and visual acuity, therapeutic response, retinal thickness, intraocular pressure, visual field, anterior chamber flare value, fundus autofluorescence, OCT, OCT angiograghy and blood test. | — |
Countries
Japan
Contacts
Public ContactMariko Kano
Tokyo Women's Medical University Yachiyo Medical center Opthalmology
Outcome results
None listed